September 27, 2014

AbbVie Presents Results from Multiple Studies of Investigational Compound Veliparib in Patients with Non-Small Cell Lung Cancer at the European Society of Medical Oncology Annual Congress

Share to Facebook Share to Twitter Share to Linkedin Email Sign Up for Alerts Print